

















http://dA comparison between aortobifemoral bypass and
aortoiliac kissing stents in patients with complex
aortoiliac obstructive diseaseWalter Dorigo, MD,a Gabriele Piffaretti, MD, PhD,b Filippo Benedetto, MD,c Antonino Tarallo, MD,b
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and Messina, ItalyABSTRACT
Objective: The aim of this study was to retrospectively compare early and late results of aortobifemoral bypass and
endovascular recanalization with the kissing stent technique in the management of TransAtlantic Inter-Society
Consensus II (TASC II) C and D lesions in the aortoiliac district in a multicenter study.
Methods: From January 2006 to December 2013, 210 open and endovascular interventions for TASC II class C and D
aortoiliac obstructive lesions were performed at three Italian teaching hospitals. In all the cases, the intervention was
performed for aortic and bilateral iliac involvement. An aortobifemoral bypass was performed in 82 patients (group 1); in
the remaining 128, an endovascular recanalization with the kissing stent technique was carried out (group 2). Early results
in the two groups were compared with the c2 test. Follow-up results were analyzed with Kaplan-Meier curves and
compared with log-rank test. Univariate and multivariate (forward Cox regression) analysis to identify potentially signif-
icant predictors of primary patency in the whole study group was performed.
Results: Patients in group 2 were more frequently female and more frequently had diabetes and arterial hypertension
than patients in group 1. The indication for surgical intervention was the presence of critical limb ischemia in 29 cases in
group 1 (35%) and in 31 cases in group 2 (24%; P ¼ .07). Technical success in group 2 was 98.5%; two patients required
immediate conversion to open surgery for iliac rupture. There was one perioperative death in group 1 (mortality rate, 1%;
P ¼ .2 in comparison with group 2). Four perioperative thromboses occurred, two in group 1 and two in group 2 (in one
case requiring conversion to open surgical intervention), and no amputations at 30 days were recorded. Cumulative
postoperative local and systemic complications occurred in 17 patients in group 1 (20.5%) and in 9 patients in group 2 (7%;
P < .001). Mean duration of follow-up was 38 months (range, 1-96 months). Survival rates at 6 years were 65.5% (standard
error [SE], 0.08) in group 1 and 83.5% (SE, 0.08) in group 2 (P ¼ .08; log-rank, 2.2). At the same time interval, primary,
assisted primary, and secondary patency rates were similar; reintervention rates were 6% in group 1 (SE, 0.05) and 11% in
group 2 (SE, 0.04; P ¼ .3; log-rank, 0.8). Univariate and multivariate analysis showed that only the presence of critical limb
ischemia was independently associated with poorer primary patency during follow-up (hazard ratio, 2.4; 95% confidence
interval, 0.9-6.4; P ¼ .05).
Conclusions: In this multicenter experience, endovascular repair of aortoiliac complex lesions with the kissing
stent technique provided similar satisfactory early and late results to those obtained with open surgery. (J Vasc Surg
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x.doi.org/10.1016/j.jvs.2016.06.107Aortobifemoral (AbF) bypass grafting and open endarter-
ectomy remain effective and durable treatment options
for aortoiliac occlusive disease (AIOD), but in the most
recent years, endovascular revascularization has been
used increasingly as an alternative to conventional surgery
with good clinical results.1-3 In particular, the “kissing stent”
technique has been proposed for the treatment of com-
plex aortoiliac lesions; it is particularly attractive for patients
with high surgical risk because complications andmortal-
ity of AbF bypass still remain significant issues.4-7 Moreover,
in more complex disease patterns, such as those with the
obstruction extending beyond or those with an associated
severe femoral artery disease, hybrid technique using
femoral artery endarterectomy in combination with
aortoiliac kissing stents has emerged to extend the appli-
cability of an endovascular approach.8-1199
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January 2017Thus, optimal management of AIOD is still under
debate. AbF bypass proved to have durable results, but
kissing stent series showed fewer postoperative compli-
cations and good durability with results resembling
those of open surgery, and operative options are not
lost even if kissing stents have failed. However, few
studies have directly compared AbF bypass grafting
and the kissing stent technique, often including patients
with heterogeneous clinical conditions.11-14 The purpose
of this study was to retrospectively compare the early
and late outcomes of AbF bypass grafting vs kissing
stents in the treatment of complex AIOD.METHODS
Study group. From January 2006 to December 2013,
461 open and endovascular interventions for AIOD were
performed in three teaching hospitals. Data concerning
these interventions were prospectively recorded in the
certified institutional registry at each participating cen-
ter. Informed consent for the treatment of personal
data was acquired for each patient for insertion in the
prospective registry, but the retrospective analysis of
the data did not require approval of the Institutional
Review Board.
Starting from January 2014, the data of each center
were retrospectively merged in only one created in the
coordinator center and containing main anatomic, clin-
ical, diagnostic, and technical variables. This database
also contained perioperative (<30 days) results and all
relevant clinical and diagnostic data collected during
follow-up. There were 293 interventions performed for
TransAtlantic Inter-Society Consensus (TASC II) classifica-
tion C and D lesions15; patients who underwent open or
endovascular unilateral treatment were excluded from
the analysis. Therefore, the remaining 210 interventions
performed for aortic or bilateral iliac involvement formed
our study group. Interventions consisted of surgical AbF
bypass grafting in 82 cases (39%, group 1) and the kissing
stent technique in 128 cases (61%, group 2).
Diagnostic workup and surgical technique. Preopera-
tive diagnostic assessment consisted of ankle-brachial
index (ABI) measurement and duplex ultrasound scan-
ning and computed tomography angiography of the
aorta and iliac-femoral axis in all the cases. Patients were
operated on in the presence of severe lifestyle-limiting
intermittent claudication after the failure of other con-
servative measures or in the presence of critical limb
ischemia (CLI). The anatomic indication for open inter-
vention has substantially changed during the years.
Whereas in the first years of the examined period AbF
bypass was performed in patients with occlusion or
subocclusion of the terminal aorta and of the iliac axes,
open surgical revascularization was reserved in the most
recent period for patients with total occlusion of the
infrarenal aorta starting from just below the origin of therenal arteries, for patients with severe and diffuse calci-
fication of the aorta and iliac arteries, and for less com-
plex lesions after the failure of a previous endovascular
attempt. On the other hand, a progressive widening of
the indications for endovascular treatment occurred,
from iliac lesions with minimal aortic involvement in the
first years to more complex lesions in recent years;
nowadays, all the patients undergo a preoperative
feasibility assessment for an endovascular primary
approach. Moreover, the general condition of the pa-
tients has also been taken into account in choosing one
operative strategy; in patients with severe comorbidities,
an endovascular approach even in the presence of
extensive aortoiliac disease has often been considered.
The annual trend of the interventions in the examined
period is shown in Fig 1.
Open surgical interventions were performed in the
operating room under general anesthesia with standard
technique with a transperitoneal approach to the aortoil-
iac axis and a longitudinal approach to the femoral bifur-
cations. A bifurcated graft with an end-to-side aortic
anastomosis was used in all the cases. The distal anasto-
moses were performed in an end-to-side fashion at the
level of the distal common femoral artery. In selected
patients with concomitant occlusive disease of the
femoral bifurcation and of the superficial femoral artery,
endarterectomy of the bifurcation was carried out and
the distal anastomosis was extended into the proximal
deep femoral artery.
Kissing stents were performed by the same vascular
surgeons in the operating room or in the angiographic
suite on the basis of local facilities; local anesthesia was
supplemented with intravenous sedation or analgesia
when required. A standard technique of arterial access
with a unilateral or bilateral femoral approach was pref-
erentially used; concomitant left brachial access was
used in selected cases. In case of complex lesions
involving the femoral bifurcation, a hybrid approach
was performed; in all cases, femoral endarterectomy
was closed with a silver-bonded Dacron or pericardial
or polyurethane patch. At that time, we punctured the
center of the patch, and a retrograde working sheath
was placed once inflow had been restored. An intralumi-
nal technique of arterial recanalization was initially
attempted whenever possible. In case of long occlusions,
a subintimal recanalization with a brachial approach was
often unavoidable. After arterial recanalization, a stan-
dard kissing stent technique was performed, with the
placement of the proximal stent ends at a higher level
than the aortic bifurcation or the proximal extension of
the lesion.7 In general, we do not cross the inguinal liga-
ment with the distal edge of the stents to avoid fractures.
Our policy was to use self-expanding stents for lesions
between 2 and 10 cm in length. Balloon-expandable
stents were used preferentially for focal, ostial, and
severely calcified lesions. Self-expanding covered stents
Fig 1. Distribution of interventions during the study period.
AbF, Aortobifemoral; Ks, kissing stents.
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when the ipsilateral hypogastric artery was occluded, or
for severely calcified lesions. All patients received short-
term antibiotic prophylaxis at induction and hepariniza-
tion (40 IU/kg) at the beginning of the endovascular pro-
cedure or just before femoral clamping. Postoperatively,
group 1 was prescribed single antiplatelet therapy ad
infinitum; patients in group 2 usually had double anti-
platelet treatment for at least 24 months and single anti-
platelet treatment thereafter; warfarin was continued
when it was already used preoperatively. Follow-up
included clinical visit with ABI and duplex ultrasound
examination at 6-month intervals during the first year
and once per year thereafter. During ultrasound exami-
nations, the patency of the treated vessels and the status
of the inflow and outflow arteries were assessed. Signifi-
cant (>70%) restenosis of the treated segment was
defined as a significant increase of the peak systolic
velocity at the stenotic site >250 cm/s; occlusion was
defined as absence of flow into the treated vessels.
Computed tomography angiography was performed in
such cases and if symptoms were suspected for a recur-
rent aortoiliac disease as well.
Definitions. Comorbidities and risk factors were defined
as previously described.2,7 The aortoiliac-femoral lesion
was defined according to the TASC II classification,
and the clinical status was defined according to the
Rutherford classification.15 Early (intraoperative and
<30 days) results were analyzed in terms of death,
thrombosis, reinterventions, and occurrence ofmajor local
and systemic complications defined according to rec-
ommended standards for reports dealing with lower ex-
tremity ischemia.16 In group 2, we assessed technical
success, defined as a <20% residual stenosis at comple-
tion angiography, and conversion to open surgery, defined
as technical failure followed by immediate surgical repair.Primary patency was defined as uninterrupted patency
without procedures performed on or at the margin of the
treated segment. Loss of patency was diagnosed when
ABI deterioration was associated with duplex ultrasound
evidence of significant restenosis, requiring or not a sec-
ondary intervention to maintain arterial patency, or
thrombosis of the treated segment. Follow-up results
were analyzed in terms of survival, primary and secondary
patency (defined as restored patency through the original
treated segment), assisted primary patency (defined as
the success of procedures carried out on a still patent
segment to prevent its thrombosis), and freedom from
reinterventions. The analysis of follow-up results was
stopped at December 2014.
Statistical analysis. Statistical analysis was performed
by means of SPSS 20.0 for Windows (IBM Corp, Armonk,
NY). Results are presented as mean 6 standard deviation
or median with range for continuous variables and num-
ber (percentage) for categorical variables. Continuous
variables were analyzed with c2 test and Fisher exact
test, when necessary. Statistical significance was defined
as P < .05. The follow-up index for late survival in the
overall study group and in both groups was assessed.17 It
was defined as the ratio between the investigated follow-
up period and the theoretically possible follow-up period
up to December 2014. Follow-up data were analyzed by
life-table analysis (Kaplan-Meier test), and results in the
two groups were compared by means of log-rank test.
A univariate analysis to identify potentially significant
predictors of primary patency in the whole study group
was performed with Kaplan-Meier survival estimates and
log-rank test for each covariate. Associations that yielded
a P value < .2 on univariate screen were then included in
a forward Cox regression analysis with measurement of
hazard ratio and confidence intervals (significance
criteria 0.25 for entry, 0.05 for removal). Examined cova-
riates and their definitions are reported in Table I.
RESULTS
Clinical and morphologic data. Demographic data,
comorbidities, and risk factors are shown in Table II.
Briefly, mean age was similar, but in group 2, there were
more men than in group 1 as well as a more frequent
history of arterial hypertension and diabetes mellitus.
All the patients had a TASC II C and D lesion at the time
of the intervention. Patients in group 1 had a TASC II D
lesion in most cases; among patients in group 2, a
TASC II C lesion was present in about 40% of the cases
(Table III). The frequency of TASC II C and D lesions in
group 2 during the years is shown in Fig 2.
Among patients in group 1, aortic involvement was
present in 77 patients, whereas five patients had isolated
bilateral iliacdisease. Among the former, concomitant uni-
lateral or bilateral iliac occlusion was present in 74 cases;
three patients had bilateral iliac stenoses. Among the five
Table II. Demographic data, comorbidities, and main risk





Male gender 71 (86) 97 (75) .03
Mean age, years 63.3 65.7 .1
Smoker or past smoker 50 (61) 66 (51) .1
Arterial hypertension 59 (72) 109 (85) .03
Hyperlipemia 48 (58) 68 (53) .3
Coronary artery disease 23 (28) 31 (24) .5
Diabetes 13 (16) 35 (27) .05
Chronic renal failure 2 (2.5) 8 (6.5) .2
Values are presented as number (%) except as noted.





CLI 29 (35) 31 (24) .08
Rutherford class
Class 3 53 (65) 97 (76) .08
Class 4 23 (28) 23 (18)
Class 5 4 (5) 7 (5)
Class 6 2 (2) 1 (1)
TASC II lesions <.001
C class 5 (6) 51 (39)
D class 77 (94) 77 (61)
Iliac unilateral or
bilateral occlusion
77 (94) 86 (67) <.001
CLI, Critical limb ischemia; TASC II, TransAtlantic Inter-Society
Consensus II.
Values are presented as number (%).
Fig 2. Distribution of TransAtlantic Inter-Society Consensus
II (TASC-II) lesions in patients of group 2 during the study
period.
Table I. Examined covariates and their definitions for
univariate analysis
Covariate Definition
Gender Male or female patients
Older age Patient aged 70 years or older
Reintervention Intervention performed in a
previously revascularized aortoiliac
axis (open or endovascular)
Diabetes mellitus Need for specific antidiabetic drugs
Coronary artery
disease
Prior myocardial infarction or surgical
or percutaneous revascularization
Hyperlipemia Need for specific drugs
Arterial hypertension Need for specific drugs
CLI Presence of rest pain or ulcers
TASC II class TASC II C or D class
Iliac status Iliac unilateral or bilateral occlusion
Intervention Open or endovascular intervention
CLI, Critical limb ischemia; TASC II, TransAtlantic Inter-Society
Consensus II.
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iliac occlusion and two had diffuse bilateral stenoses at
the levelof thecommonandexternal iliacarteries. Ingroup
2, four patients had a complete occlusion of the infrarenal
aorta and of both common iliac arteries. In 61 cases,
stenotic involvement of the terminal aorta was present
with concomitant iliac disease; in the remaining cases,
only bilateral iliac stenoses or occlusions were present.
Overall, unilateral or bilateral iliac occlusion was present
in 94% of patients in group 1 (77 cases) and in 67% of
patients (86 cases) in group 2 (P < .001). In group 1, five
patients were operated on after the late failure of a pre-
vious endovascular intervention (unilateral iliac stenting
in three cases and bilateral iliac stenting in the remaining
two); in one case, the intervention was performed after a
previous failed bilateral femoral endarterectomy and
patching. These patients were not part of group 2 as
they had been operated on in other hospitals (two cases)
or in the participating hospitals before the beginning ofthe study period (three cases). All the patients in group
2 had a primary intervention.
Preoperative mean ABI was 0.27 6 0.17 in group 1 and
0.44 6 0.21 in group 2 (P ¼ .06).
Technical details. In group 1, all the interventions con-
sisted of an AbF bypass, Dacron in 57 (69.5%; silver
impregnated, n ¼ 2) and expanded polytetrafluoroethy-
lene in the remaining 25 (30.5%). Unilateral or bilateral
endarterectomy with patching of the femoral arteries
was performed in 12 cases. In two patients, concomitant
unilateral below-the-knee femoropopliteal bypass graft
was performed. In group 2, all patients had kissing stents
at the aortic bifurcation; ipsilateral and contralateral
percutaneous femoral access was used in 83 cases,
whereas a concomitant percutaneous left brachial ac-
cess was used in 32. The remaining 13 patients had a





Technical failure d 2 (1.5%) .3
Intraoperative complications
Rupture d 2 (1.5%) .3
Local complications
Retroperitoneal hematoma 1a d
Femoral hematoma 4b 2b
Brachial thrombosis d 1c
Femoral pseudoaneurysm d 1e
Wound infection/dehiscence 2d d
Femoral thrombosis d 1e
Brachial AVF d 1d






aTreated with surgical drainage.
bTreated with surgical drainage in two cases.
cTreated with surgical thrombectomy.
dMedically treated.
eTreated with surgical repair.
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The lesions were successfully crossed in all the cases.
Twelve different types of commercially available stents
were used: in 106 cases, a nitinol stent; in 17 cases, a
covered stent; and in the remaining 5 cases, a steel stent.
The mean length of the stented iliac arteries was 15.5 6
9.5 cm. In 84 cases, two stents were just placed at the
iliac aortic bifurcation; in the remaining 44 cases, a mean
number of 2.7 stents were used down the common into
the external iliac artery. Concomitant associated open
surgical intervention was performed in six patients and
consisted of femoral endarterectomy and patching in all
the cases. In one case, concomitant renal angioplasty
and stenting for a severe right renal artery stenosis was
performed.
Early (<30 days) results. In group 2, technical success
was 98.5% (n ¼ 126); two patients, one operated on for
intermittent claudication and one for rest pain, required
intraoperative conversion to open surgery for iliac
rupture. One perioperative death in group 1 was due to
acute myocardial infarction (mortality rate, 1%). Four
cases of perioperative thrombosis occurred, two in each
group (2% vs 1.5%; P ¼ .6). In group 1, thrombosis
occurred at postoperative days 12 and 20; in both cases,
the patients had been operated on for rest pain, and
the complication was treated with a new bypass graft.
In group 2, one unilateral stent thrombosis occurred at
postoperative day 2, and it was successfully treated
with surgical thrombectomy; one patient had a bilateral
stent thrombosis at postoperative day 7 that required
conversion to AbF bypass. Both patients had been oper-
ated on for intermittent claudication. No amputations
were performed. Local complications occurred in seven
cases in group 1 (8.5%) and in six cases in group 2 (5%;
P ¼ .03); the kind and distribution of intraoperative and
perioperative local complications are listed in Table IV.
Major morbidity occurred in 10 cases in group 1 (12%) and
in three cases in group 2 (2%; P ¼ .006; Table IV). The
overall rate of perioperative complications, excluding
thromboses, was 20.5% (17 patients) in group 1 and 7% (9
patients) in group 2 (P < .001).
At 30 days, mean ABI was 0.82 6 0.16 in group 1 and
0.91 6 0.13 in group 2 (P ¼ .08).
Follow-up results. All patients who survived the opera-
tion entered the follow-up; mean duration of follow-up
was 38.1 months (range, 1-96), and 199 (94.5%) patients
had regular postoperative follow-up visits. The mean
cumulative follow-up index for survival was 0.68 (range,
0.05-1), and it was similar between the two groups
(0.65 6 0.29 in group 1 and 0.7 6 0.28 in group 2; P ¼ .9).
During follow-up, 26 deaths occurred, 13 in each group.
Estimated 72-month survival rates were 65.5% (standard
error [SE], 0.08) in group 1 and 83.5% (SE, 0.05) in group 2
(P ¼ .1; log-rank, 2.4).Significant restenosis of the treated vessel occurred in
two cases in group 2, successfully treated in both pa-
tients with a new endovascular procedure. Eleven throm-
boses were recorded during follow-up, 1 in group 1 and 10
in group 2. The patient in group 1, operated on for CLI, at
13 months developed a right iliac limb thrombosis, suc-
cessfully treated with surgical thrombectomy and
femoral patching. In group 2, five thromboses occurred
in patients operated on for intermittent claudication
(one case) and for CLI (four cases) and were successfully
treated with a new endovascular procedure; in five cases,
the occlusion led to mild claudication and the patients
were medically managed. There were no conversions to
open surgery among patients of group 2.
Primary patency rates at 6 years were 95.5% (SE, 0.03) in
group 1 and 83% (SE, 0.04) in group 2 (P ¼ .07; log-rank,
3.3). The corresponding rates of assisted primary patency
were 95.5% (SE, 0.03) and 86% (SE, 0.05), respectively
(P ¼ .1; log-rank, 2.2). Estimated secondary patency rates
at 72 months were 97% (SE, 0.2) in group 1 and 93%
(SE, 0.03) in group 2 (P ¼ .6; log-rank, 0.2). At the same
time interval, freedom from reinterventions was 94%
(SE, 0.03) in group 1 and 89% (SE, 0.04) in group 2 (P ¼
.3; log-rank, 0.8). No amputations were recorded in both
groups. Kaplan-Meier curves for long-term outcomes
are reported in Fig 3.
Univariate analysis for factors affecting primary patency
in the whole study group is reported in Table V. At
Fig 3. Kaplan-Meier curveswith number of patients at risk and standard error (S.E.) at different follow-up times for
primary patency (a), assisted primary patency (b), secondary patency (c), and freedom from reintervention (d).
104 Dorigo et al Journal of Vascular Surgery
January 2017
Table V. Univariate analysis for primary patency
Primary patency at
6 years, % Log-rank P
































CLI, Critical limb ischemia; TASC II, TransAtlantic Inter-Society
Consensus II.
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independently associated with poorer primary patency
during follow-up (hazard ratio, 2.4; 95% confidence inter-
val, 0.9-6.4; P ¼ .05).
DISCUSSION
Both AbF bypass grafting and the kissing stent tech-
nique are commonly performed, but only a few studies
have addressed a direct comparison because of the diffi-
culty in matching these patients.18,19 This study is the
analysis of two recent cohorts of patients treated in
referral centers in a short period of inclusion compared
with the similar published papers.11-14
Volume at the physician and hospital levels appears to
be a robust predictor of patient outcomes after AIOD
treatment, either for open surgery or for endovascularintervention.19,20 Despite a progressive decrease in the
number of AbF bypass grafts per year, Patel et al
showed that with only minor exception, endovascular
surgery has not appreciably increased the complexity
of open aortic operations performed for AIOD.21 Our
experience is in line with these findings. We have
high-volume programs for both of these interventions,
and although our patients were not randomized, we
observed no drastic differences in outcome between
these two therapies.
The ongoing debate on the optimal operative manage-
ment of complex AIOD is related to which of these two
techniques is superior in terms of clinical and operative
outcomes. The durability of the AbF bypass is offset by
the low rate of morbidity and mortality of the kissing
stent technique, which on the contrary has been ques-
tioned in terms of long-term patency and need of rein-
terventions.19,21-23 A recent review showed that AbF
bypass grafting had a higher mortality than the kissing
stent technique; that study highlighted the impact of
the higher incidences of coronary and respiratory dis-
eases in patients undergoing open repair.19 This was sur-
prising, probably because of the fact that anatomically
suitable lesions were preferentially treated with the
kissing stent technique regardless of the patients’
comorbidities.11,12 Our data combine these two observa-
tions; although cardiorespiratory risk factors were homo-
geneously distributed in the two groups, we can confirm
that mortality and major morbidity were mainly
hampered by cardiac events. This finding deserves a
comment. Danczyk et al reported a better survival in
patients undergoing redo AbF bypass grafting compared
with those undergoing primary operation despite a
higher percentage of cardiac risk factors.24 The reason
that a much more invasive operation has better clinical
outcomes lies in the fact that redo patients, at that
time, were on a better medical regimen; this may under-
line the importance on outcomes during primary
operation, and it could be a coexplanation of the litera-
ture and personal results. Last but not least, it confirms
that in contrast to infrainguinal distal revascularization,
endovascular-first treatment does not preclude an effec-
tive open rescue; this is also supported by the findings of
Patel et al, who demonstrated that endovascular surgery
has not appreciably increased the complexity of open
aortic operations performed for AIOD.21
When we consider cardiovascular risk factors and
their impact on clinical outcomes, we should take into
account that most of these patients presented with a
more important severity of ischemia.11,14,19 Among factors
influencing postoperative outcomes, CLI is a known
marker of poorer results.15 This holds true also in our
study; CLI was an independent risk factor for worse out-
comes. Although AbF bypass grafting and kissing stent
technique patencies did not differ in the long run, overall
patency results were negatively affected by CLI. Our data
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showed that the status of the runoff vessels is another
important factor negatively affecting the patency of
such interventions.11 In their experience, patients who
required concomitant distal revascularization along
with either AbF bypass or kissing stents had dismal
patency rates, reflecting the more severe atherosclerotic
burden in a patient with CLI.
Considering the durability of these two types of treat-
ment, long-term survival is another primary end point
to be evaluated. Disappointingly, it is not surprising to
find conflicting data. Kashyap et al reported a survival
rate of 80% at 3 years in both groups; Sachwani et al
had results at 6 years with 76% survival for AbF bypass
and 68% for kissing stents.11,14 At the same time point,
our results are exactly the opposite, with better survival
for the endovascular group, independent of the initial
age of patients in the two groups. Considering long-
term survival, we should underline that our study is
consistent with many series of interventions for complex
AIOD in which most patients were treated for claudica-
tion rather than for CLI.11-14,19 One possible explanation
for the better survival in group 2 is represented by the
different long-term postoperative regimen, with a wide
use of double antiplatelet treatment in the endovascu-
lar group, probably favoring a better control of cardio-
vascular events during the years. Primary, assisted
primary, and secondary patency rates were similar be-
tween the two groups; there was, however, a trend to-
ward better results for patients in group 1, particularly
when primary and assisted primary patency were exam-
ined. This is a common finding in the prior vascular liter-
ature, and in this study it could be due to type II
statistical errors.19 One can suppose that with a larger
number of patients and a longer follow-up time, the dif-
ference could become significant; however, all the
patients needing a reintervention in group 2 were
treated with a novel endovascular approach, allowing
the gap between the two groups to be further reduced
in terms of secondary patency.
Limitations. Limitations of our study are worthy of
mention and inherent to the study design. This is a retro-
spective nonrandomized study, with heterogeneous
criteria for the choice of the treatment and progressive
changes in indications during the years. Moreover, we
had a higher percentage of more complex lesions in
group 1, even if the cumulative number of TASC II C and
D lesions was similar in the groups. Furthermore, we did
not perform an analysis on costs and postoperative sexual
dysfunction. On the other hand, the two groups matched
well under a clinical point of view, and the mild anatomic
differences between them did not affect late outcomes;
moreover, it involves referral centers with a large number
of treated cases, and follow-up was consistent, allowing
assessment of durability and survival.CONCLUSIONS
Endovascular repair of aortoiliac complex lesions with
the kissing stent technique in suitable patients in this
multicenter experience provided satisfactory early and
late results similar to those obtained with open aortofe-
moral bypass surgery. The rate of perioperative complica-
tions was lower in patients undergoing endovascular
treatment, and there was a trend toward better long-
term survival. The numerically higher rate of reinterven-
tion over the time observed in endovascularly treated
patients is mitigated by the fact that most of the long-
term complications were successfully treated with
another endovascular procedure.
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